| Printable Copy |
 |
| Printable Copy |
|
MMWR Morb Mortal Wkly Rep. 2017 May 5;66(17):436-443. doi: 10.15585/mmwr.mm6617a2.
Progress Toward Measles Elimination - African Region 2013-2016.
Masresha BG Dixon MG Kriss JL Katsande R Shibeshi ME Luce R Fall A Dosseh ARGA Byabamazima CR Dabbagh AJ Goodson JL Mihigo R.
Abstract
In 2011 the 46 World Health Organization (WHO) African Region (AFR) member states established a goal of measles elimination* by 2020 by achieving 1) ≥95% coverage of their target populations with the first dose of measles-containing vaccine (MCV1) at national and district levels; 2) ≥95% coverage with measles-containing vaccine (MCV) per district during supplemental immunization activities (SIAs); and 3) confirmed measles incidence of <1 case per 1 million population in all countries (1). Two key surveillance performance indicator targets include 1) investigating ≥2 cases of non- measles febrile rash illness per 100000 population annually and 2) obtaining a blood specimen from ≥1 suspected measles case in ≥80% of districts annually (2). This report updates the previous report (3) and describes progress toward measles elimination in AFR during 2013-2016. Estimated regional MCV1 coverage† increased from 71% in 2013 to 74% in 2015. Seven (15%) countries achieved ≥95% MCV1 coverage in 2015.¶ The number of countries providing a routine second MCV dose (MCV2) increased from 11 (24%) in 2013 to 23 (49%) in 2015. Forty-one (79%) of 52 SIAs** during 2013-2016 reported ≥95% coverage. Both surveillance targets were met in 19 (40%) countries in 2016. Confirmed measles incidence in AFR decreased from 76.3 per 1 million population to 27.9 during 2013-2016. To eliminate measles by 2020 AFR countries and partners need to 1) achieve ≥95% 2-dose MCV coverage through improved immunization services including second dose (MCV2) introduction; 2) improve SIA quality by preparing 12-15 months in advance and using readiness intra-SIA and post-SIA assessment tools; 3) fully implement elimination-standard surveillance††; 4) conduct annual district-level risk assessments; and 5) establish national committees and a regional commission for the verification of measles elimination.
PMID:28472026